Literature DB >> 20518554

Synthesis and evaluation of amino-modified alpha-GalCer analogues.

Matthias Trappeniers1, René Chofor, Sandrine Aspeslagh, Yali Li, Bruno Linclau, Dirk M Zajonc, Dirk Elewaut, Serge Van Calenbergh.   

Abstract

Alpha-GalCer analogues featuring a phytoceramide 3- and 4-amino group have been synthesized. A Mitsunobu reaction involving phthalimide was employed for the introduction of the amino groups at the 3- and 4-positions of suitable phytosphingosine-derived precursors. The influence of these modifications on the interaction with the T-cell receptor of NKT cells was investigated, as well as the capacity of the amino-modified analogues to induce a cytokine response after in vivo administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518554      PMCID: PMC2903208          DOI: 10.1021/ol100934z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  20 in total

1.  Total synthesis of alpha-galactosyl cerebroside.

Authors:  S Figueroa-Pérez; R R Schmidt
Journal:  Carbohydr Res       Date:  2000-09-08       Impact factor: 2.104

2.  A new synthesis of prumycin.

Authors:  A Hasegawa; N Aritake; M Kiso
Journal:  Carbohydr Res       Date:  1976-10       Impact factor: 2.104

3.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

4.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.

Authors:  Karl O A Yu; Jin S Im; Alberto Molano; Yves Dutronc; Petr A Illarionov; Claire Forestier; Nagatoshi Fujiwara; Isa Arias; Sachiko Miyake; Takashi Yamamura; Young-Tae Chang; Gurdyal S Besra; Steven A Porcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

5.  The crystal structure of human CD1d with and without alpha-galactosylceramide.

Authors:  Michael Koch; Victoria S Stronge; Dawn Shepherd; Stephan D Gadola; Bini Mathew; Gerd Ritter; Alan R Fersht; Gurdyal S Besra; Richard R Schmidt; E Yvonne Jones; Vincenzo Cerundolo
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

Review 6.  Immunotherapeutic potential for ceramide-based activators of iNKT cells.

Authors:  Celia R Berkers; Huib Ovaa
Journal:  Trends Pharmacol Sci       Date:  2005-05       Impact factor: 14.819

7.  Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.

Authors:  Randal D Goff; Ying Gao; Jochen Mattner; Dapeng Zhou; Ning Yin; Carlos Cantu; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  J Am Chem Soc       Date:  2004-10-27       Impact factor: 15.419

8.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

9.  Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent.

Authors:  Oliver Plettenburg; Vera Bodmer-Narkevitch; Chi-Huey Wong
Journal:  J Org Chem       Date:  2002-06-28       Impact factor: 4.354

10.  Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice.

Authors:  M Morita; K Motoki; K Akimoto; T Natori; T Sakai; E Sawa; K Yamaji; Y Koezuka; E Kobayashi; H Fukushima
Journal:  J Med Chem       Date:  1995-06-09       Impact factor: 7.446

View more
  1 in total

Review 1.  Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.

Authors:  James E East; Andrew J Kennedy; Tonya J Webb
Journal:  Med Res Rev       Date:  2012-12-13       Impact factor: 12.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.